136 related articles for article (PubMed ID: 6844805)
1. Recent developments in the management of anaerobic infections.
Bartlett JG
Rev Infect Dis; 1983; 5(2):235-45. PubMed ID: 6844805
[TBL] [Abstract][Full Text] [Related]
2. Therapy for infections due to anaerobic bacteria: an overview.
Finegold SM
J Infect Dis; 1977 Mar; 135 Suppl():S25-9. PubMed ID: 321708
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of anaerobic bacteria to five antimicrobial agents and demonstration of resistance of Bacteroides fragilis to clindamycin.
Sofianou D; Douboyas J; Papapanagiotou J; Paradelis AG
Methods Find Exp Clin Pharmacol; 1982; 4(3):173-7. PubMed ID: 7121128
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of resistance and resistance transfer in anaerobic bacteria: factors influencing antimicrobial therapy.
Tally FP; Cuchural GJ; Malamy MH
Rev Infect Dis; 1984; 6 Suppl 1():S260-9. PubMed ID: 6326243
[TBL] [Abstract][Full Text] [Related]
5. Bacteroides fragilis: current susceptibilities, mechanisms of drug resistance, and principles of antimicrobial therapy.
Cuchural GJ; Tally FP
Drug Intell Clin Pharm; 1986; 20(7-8):567-73. PubMed ID: 3488895
[TBL] [Abstract][Full Text] [Related]
6. Treatment of anaerobic infections: an overview.
Finegold SM
Scand J Infect Dis Suppl; 1985; 46():89-95. PubMed ID: 3865355
[TBL] [Abstract][Full Text] [Related]
7. Aspects on antibacterial treatment of anaerobic infections.
Nordbring F; Nord CE
Scand J Infect Dis Suppl; 1982; 35():59-62. PubMed ID: 6762654
[TBL] [Abstract][Full Text] [Related]
8. Management of anaerobic infections.
Finegold SM; Bartlett JG; Chow AW; Flora DJ; Gorbach SL; Harder EJ; Tally FP
Ann Intern Med; 1975 Sep; 83(3):375-89. PubMed ID: 1190633
[TBL] [Abstract][Full Text] [Related]
9. Effects of medium and inoculum on antimicrobial susceptibility of anaerobic bacteria.
Rahimi A; Martin WJ; Washington JA
Am J Clin Pathol; 1974 Sep; 62(3):425-7. PubMed ID: 4496770
[No Abstract] [Full Text] [Related]
10. Therapeutic efficacy of moxifloxacin, a new quinolone, in the treatment of experimental intra-abdominal abscesses induced by Bacteroides fragilis in mice.
Thadepalli H; Chuah SK; Gollapudi S
Chemotherapy; 2004 Jun; 50(2):76-80. PubMed ID: 15211081
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial therapy for anaerobic infections.
Finegold SM
Scand J Gastroenterol Suppl; 1984; 91():61-72. PubMed ID: 6588490
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics and antimicrobial susceptibilities of anaerobic bacteremia in an acute care hospital.
Tan TY; Ng LS; Kwang LL; Rao S; Eng LC
Anaerobe; 2017 Feb; 43():69-74. PubMed ID: 27890724
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model.
Moody JA; Fasching CE; Sinn LM; Gerding DN; Peterson LR
J Lab Clin Med; 1990 Feb; 115(2):190-5. PubMed ID: 1967626
[TBL] [Abstract][Full Text] [Related]
14. Effect of prophylactic antibiotics upon mixed infections with Bacteroides fragilis.
Brook I
Surg Gynecol Obstet; 1987 Dec; 165(6):491-5. PubMed ID: 3317944
[TBL] [Abstract][Full Text] [Related]
15. Comparative chemotherapeutic activity of temafloxacin, cefoxitin, clindamycin, imipenem and ampicillin/sulbactam against Bacteroides fragilis in a mouse subcutaneous abscess model.
Alder J; Clement JJ
J Antimicrob Chemother; 1993 Feb; 31(2):303-11. PubMed ID: 8463174
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial therapy of anaerobic infections, 1991.
Sanders CV; Aldridge KE
Pharmacotherapy; 1991; 11(2 ( Pt 2)):72S-79S. PubMed ID: 2041835
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial resistance in the Bacteroides fragilis group in faecal microbiota from healthy Danish children.
Sydenham TV; Jensen BH; Petersen AM; Krogfelt KA; Justesen US
Int J Antimicrob Agents; 2017 May; 49(5):573-578. PubMed ID: 28366659
[TBL] [Abstract][Full Text] [Related]
18. In Vitro Activity of Ceftolozane-Tazobactam against Anaerobic Organisms Identified during the ASPECT-cIAI Study.
Armstrong ES; Farrell DJ; Palchak M; Steenbergen JN
Antimicrob Agents Chemother; 2016 Jan; 60(1):666-8. PubMed ID: 26552971
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic management of anaerobic infections.
Brook I
Hosp Pract (Off Ed); 1982 Aug; 17(8):203, 206-7, 210-11 passim. PubMed ID: 6807815
[No Abstract] [Full Text] [Related]
20. Pathogenicity of capsulate and non-capsulate members of Bacteroides fragilis and B. melaninogenicus groups in mixed infection with Escherichia coli and Streptococcus pyogenes.
Brook I
J Med Microbiol; 1988 Nov; 27(3):191-8. PubMed ID: 2903934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
